Related Experiment Videos
T- and B-cell abnormalities in systemic lupus erythematosus
Gyorgy Nagy1, Agnes Koncz, Andras Perl
1Section of Rheumatology, Department of Medicine, State University of New York, Upstate Medical University, College of Medicine, Syracuse, NY 13210, USA.
Critical Reviews in Immunology
|June 15, 2005
Summary
Systemic lupus erythematosus (SLE) involves T-cell dysfunction, characterized by mitochondrial abnormalities and altered cell death pathways. This dysfunction contributes to inflammation and autoantibody production, driving SLE pathogenesis.
Area of Science:
- Immunology
- Autoimmunity
- Cellular Biology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- T cells in SLE patients show in vivo activation and support autoreactive B cells.
- Dysfunctional T cells in SLE are linked to abnormal signaling, defective pathways, and mitochondrial issues.
Purpose of the Study:
- To review recent advancements in understanding SLE pathogenesis.
- To highlight novel therapeutic developments for SLE.
- To explore the molecular mechanisms driving lupus autoimmunity.
Main Methods:
- Review of recent scientific literature on SLE.
- Analysis of molecular mechanisms in T-cell and B-cell dysfunction.
- Examination of mitochondrial dysfunction and cell death pathways in SLE.
Main Results:
- Lupus T cells exhibit persistent mitochondrial hyperpolarization, alkalinization, increased reactive oxygen species (ROI), and ATP depletion.
- These T-cell defects lead to altered apoptosis/necrosis balance, promoting inflammation.
- Necrotic cell components activate dendritic cells, increasing interferon-alpha and autoantibody production.
Conclusions:
- T-cell mitochondrial dysfunction is central to SLE pathogenesis.
- Altered cell death mechanisms in T cells contribute to SLE.
- B cells play active roles in SLE beyond autoantibody production.